CD133+ glioma stem cells can differentiate into CD133- tumor cells; CD133- glioma cells injected into nude rats formed tumors containing CD133+ cells (Joo et al., 2008; Wang et al., 2008). The gene discussed is PROM1; the disease is neoplasm.